December 24, 2021 Comments Off on New patent for Alkermes Inc drug LYBALVI Posted in: Patent Added Annual Drug Patent Expirations for LYBALVI Lybalvi is a drug marketed by Alkermes Inc and is included in one NDA. It is available from one supplier. There are nine patents…
The post New patent for Alkermes Inc drug LYBALVI appeared first on DrugPatentW…
December 24, 2021 Comments Off on New patent for Intra-cellular drug CAPLYTA Posted in: Patent Added Annual Drug Patent Expirations for CAPLYTA Caplyta is a drug marketed by Intra-cellular and is included in one NDA. There are nine patents protecting this drug. CAPLYTA drug price trends.…
The post New patent for Intra-cellular drug CAPLYTA appeared fi…
